Cargando…

Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers

More aggressive and therapy-resistant oestrogen receptor (ER)-positive breast cancers remain a great clinical challenge. Here our integrative genomic analysis identifies tousled-like kinase 2 (TLK2) as a candidate kinase target frequently amplified in ∼10.5% of ER-positive breast tumours. The result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jin-Ah, Tan, Ying, Wang, Xian, Cao, Xixi, Veeraraghavan, Jamunarani, Liang, Yulong, Edwards, Dean P., Huang, Shixia, Pan, Xuewen, Li, Kaiyi, Schiff, Rachel, Wang, Xiao-Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064015/ https://www.ncbi.nlm.nih.gov/pubmed/27694828 http://dx.doi.org/10.1038/ncomms12991

Ejemplares similares

Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of estrogen-receptor positive breast cancers
por: Veeraraghavan, Jamunarani, et al.
Publicado: (2014)

Targeting Prostate Cancer, the ‘Tousled Way’
por: Bhoir, Siddhant, et al.
Publicado: (2023)

The protein kinase TOUSLED facilitates RNAi in Arabidopsis
por: Uddin, Mohammad Nazim, et al.
Publicado: (2014)

The Tousled-Like Kinases as Guardians of Genome Integrity
por: De Benedetti, Arrigo
Publicado: (2012)

Molecular basis of Tousled-Like Kinase 2 activation
por: Mortuza, Gulnahar B., et al.
Publicado: (2018)

DNA damage response and repair data with pharmacological modulators of Tousled
por: Timiri Shanmugam, Prakash Srinivasan, et al.
Publicado: (2016)

Discretionary Transduction of MMP-Sensitized Tousled in Head and Neck Cancer
por: Nair, Renjith Parameswaran, et al.
Publicado: (2019)

Untousling the Role of Tousled-like Kinase 1 in DNA Damage Repair
por: Ghosh, Ishita, et al.
Publicado: (2023)

Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance
por: Li, Li, et al.
Publicado: (2020)

Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer
por: Yu, L, et al.
Publicado: (2017)

mars and tousled-like kinase act in parallel to ensure chromosome fidelity in Drosophila
por: Li, Hsing-Hsi, et al.
Publicado: (2009)

Knockdown of Tousled-like kinase 1 inhibits survival of glioblastoma multiforme cells
por: Ibrahim, Kamariah, et al.
Publicado: (2020)

Phosphorylation-Mediated Control of Histone Chaperone ASF1 Levels by Tousled-Like Kinases
por: Pilyugin, Maxim, et al.
Publicado: (2009)

The Drosophila Splicing Factor PSI Is Phosphorylated by Casein Kinase II and Tousled-Like Kinase
por: Taliaferro, J. Matthew, et al.
Publicado: (2013)

Tousled-Like Kinases Suppress Innate Immune Signaling Triggered by Alternative Lengthening of Telomeres
por: Segura-Bayona, Sandra, et al.
Publicado: (2020)

Tousled-like kinases phosphorylate Asf1 to promote histone supply during DNA replication
por: Klimovskaia, Ilnaz M, et al.
Publicado: (2014)

Tousled-like kinases stabilize replication forks and show synthetic lethality with checkpoint and PARP inhibitors
por: Lee, Sung-Bau, et al.
Publicado: (2018)

Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry
por: Simon, Bertrand, et al.
Publicado: (2022)

The Chromosomal Passenger Complex and a Mitotic Kinesin Interact with the Tousled-Like Kinase in Trypanosomes to Regulate Mitosis and Cytokinesis
por: Li, Ziyin, et al.
Publicado: (2008)

Luminal Flow Amplifies Stent-Based Drug Deposition in Arterial Bifurcations
por: Kolachalama, Vijaya B., et al.
Publicado: (2009)

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?
por: Liu, Chia-Chia, et al.
Publicado: (2023)

Purification, crystallization and preliminary X-ray diffraction analysis of the kinase domain of human tousled-like kinase 2
por: Garrote, Ana M., et al.
Publicado: (2014)

Tousled-like kinase 1 is a negative regulator of core transcription factors in murine embryonic stem cells
por: Lee, Jina, et al.
Publicado: (2018)

Tousled kinase TLK1B mediates chromatin assembly in conjunction with Asf1 regardless of its kinase activity
por: De Benedetti, Arrigo
Publicado: (2010)

High yield bacterial expression, purification and characterisation of bioactive Human Tousled-like Kinase 1B involved in cancer
por: Bhoir, Siddhant, et al.
Publicado: (2018)

Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance
por: Khalil, Md Imtiaz, et al.
Publicado: (2022)

Tousled-like kinase regulates cytokine-mediated communication between cooperating cell types during collective border cell migration
por: Xiang, Wenjuan, et al.
Publicado: (2016)

Tousled kinase TLK1B counteracts the effect of Asf1 in inhibition of histone H3–H4 tetramer formation
por: De Benedetti, Arrigo
Publicado: (2009)

ALK alteration is a frequent event in aggressive breast cancers
por: Siraj, Abdul K., et al.
Publicado: (2015)

GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer
por: Guo, Yanxia, et al.
Publicado: (2019)

Tousled-Like Kinase-Dependent Phosphorylation of Rad9 Plays a Role in Cell Cycle Progression and G2/M Checkpoint Exit
por: Kelly, Ryan, et al.
Publicado: (2013)

The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness
por: Schmidt, Ulrike, et al.
Publicado: (2021)

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations
por: Casar-Borota, Olivera, et al.
Publicado: (2020)

Irreversible EGFR Inhibitor EKB-569 Targets Low-LET γ-Radiation-Triggered Rel Orchestration and Potentiates Cell Death in Squamous Cell Carcinoma
por: Aravindan, Natarajan, et al.
Publicado: (2011)

SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling
por: Xu, Liang, et al.
Publicado: (2020)

THE TOTAL LUMINOUS EFFICIENCY OF LUMINOUS BACTERIA
por: Harvey, E. Newton
Publicado: (1925)

Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer
por: Yang, Ganglong, et al.
Publicado: (2023)

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer
por: Viotto, Davide, et al.
Publicado: (2020)

Extracellular Vesicles Induce an Aggressive Phenotype in Luminal Breast Cancer Cells Via PKM2 Phosphorylation
por: Kang, Seo Young, et al.
Publicado: (2021)

NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling
por: Yang, Yun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b1lukkfk1bqknb4dh0f5elb0po